Paper Details
- Home
- Paper Details
Real-World Effects of Mirabegron in Patients with Chronic Neurogenic Detrusor Overactivity - A Retrospective Cohort Study.
Author: KrebsJörg, PannekJürgen, RademacherFranziska, WöllnerJens
Original Abstract of the Article :
PURPOSE: To investigate the tolerability and the effects of the β-3-adrenoceptor-agonist mirabegron on urinary incontinence and urodynamic parameters in patients with chronic neurogenic detrusor overactivity (NDO). PATIENTS AND METHODS: The patient database of a spinal cord injury rehabilitation ce...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250696/
データ提供:米国国立医学図書館(NLM)
Mirabegron for Neurogenic Detrusor Overactivity: A Camel's Journey Through the Desert of Bladder Dysfunction
Neurogenic detrusor overactivity (NDO), a condition characterized by involuntary bladder contractions, can significantly impact quality of life. This study investigates the effectiveness and tolerability of mirabegron, a β-3-adrenoceptor-agonist, in patients with chronic NDO, seeking to improve bladder control and enhance overall well-being.A Oasis of Relief: Mirabegron Shows Promise in Treating NDO
Mirabegron demonstrated a clinically relevant effect in patients with chronic NDO, significantly reducing the incidence of urinary incontinence. The study also highlighted the potential of mirabegron to allow for a reduction in the dosage of antimuscarinic medications, potentially improving long-term treatment persistence. This research provides valuable insights into a potentially effective treatment for NDO, offering a glimmer of hope in the desert of bladder dysfunction.Navigating the Bladder Desert: A Camel's Guide to Better Control
Managing bladder dysfunction can be as challenging as navigating a sandstorm. This study underscores the potential benefits of mirabegron in improving bladder control and reducing the need for other medications. By working closely with healthcare professionals, individuals with NDO can find strategies to manage their condition and maintain a better quality of life. It's important to remember that even in the desert of bladder dysfunction, there can be oases of relief.Dr. Camel's Conclusion
Living with neurogenic detrusor overactivity can feel like navigating a vast and unforgiving desert. This study, like a well-placed oasis, provides a glimmer of hope. Mirabegron shows promise in improving bladder control and reducing the need for other medications. While further research is needed, this study offers a valuable step forward in the quest for effective treatments for NDO, allowing individuals to find a path towards better bladder control and a more comfortable life.Date :
- Date Completed n.d.
- Date Revised 2022-04-15
Further Info :
Related Literature
Article Analysis
SNS
PICO Info
in preparation
Languages
English
Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.